Literature DB >> 20646373

Thyroidectomy with ultrasonic dissector: a multicentric experience.

F D'Ajello1, R Cirocchi, G Docimo, A Catania, G Ardito, L Rosato, N Avenia.   

Abstract

INTRODUCTION: We have conducted a clinical controlled trial (CCT) on patients who had undergone thyroidectomy for goitre or thyroid carcinoma. The endpoint of this study was to evaluate the benefits of ultrasonic dissector vs conventional technique (vessel ligation and tight) in patients undergoing thyroid surgery. PATIENT AND METHODS: Between January 2007 and December 2009 a CCT was conducted on 2.736 consecutive patients admitted to our clinical wards, who had undergone thyroidectomy for goitre or thyroid carcinoma. They were divided in two group: 1.021 patients (203 male and 818 female) underwent thyroidectomy with ultrasonic dissector (UAS) and 1.715 patients (369 male and 1.346 female) underwent throidectomy with conventional technique (vessel ligation and tight) (CT).
RESULTS: The operative time (UAS 80 minutes mean, 50 to 120 min., vs CT 120 minutes, 70 to 180 minutes) was much lower in the thryoidectomy with UAS group. The incidence of transient laryngeal nerve palsy (UAS 17/1.021 patients. 1.6% vs CT 16/1.715 patients, 0.9%) was higher in the thyroidectomy with UAS group; the incidence of permanent laryngeal nerve palsy was similar in two groups(UAS group; there are no relevant difference in the incidence of permanent hypocalcemia (UAS 26/1.021 patients, 2.5% vs 35/1.715 patients, 2%) which was similar in two groups. Also the average post-operative hospitalization was similar in two groups (2 days).
CONCLUSIONS: Actually, the only significant advantage shown from this CCT is represented in terms of cost-effectiveness (reduction of the usage of operating room and hospitalization) for patients treated with UAS, subsequent to the significant reduction of operative duration. Although the analysis showed that the patients who were treated with ultrasonic dissection don't present more favourable results in incidence of post-operative transient complication:transient laryngeal nerve palsy (1.6% in UAS vs 0.9% in CT) and transient hypocalcaemia (9.5% in UAS vs 7.7% in CT). There is no significant difference in the incidence of permanent laryngeal nerve palsy (0.9% in UAS vs in 1% CT). The experience of surgeon is the only important factor which can influence the appearance of these complications; the usage of Ultrasonic dissector can only help surgical action but can't repair the experience of the operator.

Entities:  

Mesh:

Year:  2010        PMID: 20646373

Source DB:  PubMed          Journal:  G Chir        ISSN: 0391-9005


  13 in total

1.  Parathyroid function following total thyroidectomy using energy devices.

Authors:  Fatih Ciftci; Erdal Sakalli; Ibrahim Abdurrahman; Burak Guler
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-07-04       Impact factor: 2.503

2.  Update on sutureless thyroidectomy.

Authors:  R Ruggiero; G Docimo; A Bosco; M Lanza Volpe; G Terracciano; A Gubitosi; L Docimo
Journal:  G Chir       Date:  2018 Jan-Feb

3.  Health technology assessment and thyroid surgery.

Authors:  R Lucchini; A Sanguinetti; M Monacelli; R Triola; S Avenia; C Conti; S Santoprete; N Avenia
Journal:  G Chir       Date:  2013 Jul-Aug

4.  The impact of age and oral calcium and vitamin D supplements on postoperative hypocalcemia after total thyroidectomy. A prospective study.

Authors:  Salvatore Tolone; Ruggiero Roberto; Gianmattia del Genio; Luigi Brusciano; Domenico Parmeggiani; Vincenzo Amoroso; Giuseppina Casalino; Ignazio Verde; Alfonso Bosco; Antonio D'Alessandro; Raffaele Pirozzi; Gianluca Rossetti; Paolo Limongelli; Ludovico Docimo
Journal:  BMC Surg       Date:  2013-10-08       Impact factor: 2.102

5.  Total thyroidectomy with ultrasonic dissector for cancer: multicentric experience.

Authors:  Roberto Cirocchi; Carlo Boselli; Salvatore Guarino; Alessandro Sanguinetti; Stefano Trastulli; Jacopo Desiderio; Alberto Santoro; Fabio Rondelli; Giovanni Conzo; Domenico Parmeggiani; Giuseppe Noya; Giorgio De Toma; Nicola Avenia
Journal:  World J Surg Oncol       Date:  2012-04-27       Impact factor: 2.754

6.  Harmonic focus in total thyroidectomy plus level III-IV and VI dissection: a prospective randomized study.

Authors:  Qingqing He; Dayong Zhuang; Luming Zheng; Peng Zhou; Jixin Chai; Zhen Lv
Journal:  World J Surg Oncol       Date:  2011-10-31       Impact factor: 2.754

7.  Predictive value of nodal metastases on local recurrence in the management of differentiated thyroid cancer. Retrospective clinical study.

Authors:  Giovanni Conzo; Giovanni Docimo; Daniela Pasquali; Claudio Mauriello; Claudio Gambardella; Daniela Esposito; Ernesto Tartaglia; Cristina Della Pietra; Salvatore Napolitano; Antonia Rizzuto; Luigi Santini
Journal:  BMC Surg       Date:  2013-10-08       Impact factor: 2.102

8.  Impact of parathyroidectomy on cardiovascular outcomes and survival in chronic hemodialysis patients with secondary hyperparathyroidism. A retrospective study of 50 cases prior to the calcimimetics era.

Authors:  Giovanni Conzo; Alessandra F Perna; Vincenzo Savica; Antonietta Palazzo; Cristina Della Pietra; Diego Ingrosso; Ersilia Satta; Giovambattista Capasso; Luigi Santini; Giovanni Docimo
Journal:  BMC Surg       Date:  2013-10-08       Impact factor: 2.102

9.  Long term quality of life after laparoscopic antireflux surgery for the elderly.

Authors:  Salvatore Tolone; Giovanni Docimo; Gianmattia Del Genio; Luigi Brusciano; Ignazio Verde; Simona Gili; Chiara Vitiello; Antonio D'Alessandro; Giuseppina Casalino; Francesco Lucido; Nicola Leone; Raffaele Pirozzi; Roberto Ruggiero; Ludovico Docimo
Journal:  BMC Surg       Date:  2013-10-08       Impact factor: 2.102

Review 10.  Safety and Effectiveness of Total Thyroidectomy and Its Comparison with Subtotal Thyroidectomy and Other Thyroid Surgeries: A Systematic Review.

Authors:  Ashwini Aithal Padur; Naveen Kumar; Anitha Guru; Satheesha Nayak Badagabettu; Swamy Ravindra Shanthakumar; Murlimanju Bukkambudhi Virupakshamurthy; Jyothsna Patil
Journal:  J Thyroid Res       Date:  2016-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.